Cargando…
Development of a minimal saponin vaccine adjuvant based on QS-21
Adjuvants are materials added to vaccines to enhance the immunological response to an antigen. QS-21 is a natural product adjuvant under investigation in numerous vaccine clinical trials, but its use is constrained by scarcity, toxicity, instability, and an enigmatic molecular mechanism of action. H...
Autores principales: | Fernández-Tejada, Alberto, Chea, Eric K., George, Constantine, Pillarsetty, NagaVaraKishore, Gardner, Jeffrey R., Livingston, Philip O., Ragupathi, Govind, Lewis, Jason S., Tan, Derek S., Gin, David Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215704/ https://www.ncbi.nlm.nih.gov/pubmed/24950335 http://dx.doi.org/10.1038/nchem.1963 |
Ejemplares similares
-
Development of Improved Vaccine Adjuvants Based on
the Saponin Natural Product QS-21 through Chemical Synthesis
por: Fernández-Tejada, Alberto, et al.
Publicado: (2016) -
1238. The Novel Semisynthetic Saponin Adjuvant TQL1055 Enhances the Antibody Response to Pertussis Vaccine with an Improved Tolerability Profile over QS-21
por: Buzz, Chloe, et al.
Publicado: (2020) -
Quillaja saponin variants with central glycosidic linkage modifications exhibit distinct conformations and adjuvant activities
por: Walkowicz, William E., et al.
Publicado: (2016) -
Replacing the Rhamnose‐Xylose Moiety of QS‐21 with Simpler Terminal Disaccharide Units Attenuates Adjuvant Activity in Truncated Saponin Variants
por: Fuentes, Roberto, et al.
Publicado: (2021) -
Atomic Model and Micelle Dynamics of QS-21 Saponin
por: Pedebos, Conrado, et al.
Publicado: (2014)